FN1 and basal cell carcinoma: However, CTSH activity is dysregulated in tissues surrounding basal cell carcinoma tumors, leading to its overexpression and secretion into the extracellular space to degrade structural proteins such as collagen and fibronectin (8, 63–67), thereby regulating the structure and stability of the extracellular matrix and promoting tumor cell invasion (68, 69).